Bronchospasm
📧 Sign up to get email alerts when something new happens for Bronchospasm.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-06-04Clinical Trial Results: Avoiding Neuromuscular Blockers to Reduce Complications [Phase 4]
Phase 4 trial investigating avoidance of neuromuscular blockers to reduce complications in respiratory failure/infection; study terminated w…
-
FDA approval · 2025-12-08FDA Approved: EPINEPHRINE — Original Application (Amneal Pharmaceuticals Private Limited)
The FDA approved Amneal Pharmaceuticals' generic Epinephrine product under an Original Application (ANDA), authorizing its marketing.
-
CLINICAL_TRIALS trial_result · 2025-11-25Clinical Trial Update: INHALATION CHAMBER MANAGEMENT IN PEDIATRICS: EFFICACY OF AN EDUCATIONAL INTERVENTION IN PATIENTS DIAGNOSED WITH BRONCHOSPASM AND THEIR FAMILY CAREGIVERS. [NA]
This document reports on a completed clinical trial evaluating the efficacy of an educational intervention for inhalation chamber management…
-
FDA approval · 2024-05-21FDA Approved: THEOPHYLLINE — Original Application (Zydus Lifesciences Limited)
FDA approved an original ANDA for Theophylline by Zydus Lifesciences Limited.
-
CLINICAL_TRIALS trial_result · 2024-05-21Clinical Trial Update: Ketamine Efficacy for Acute Severe Bronchospasm in ICU: MACANUDO Trial [Phase 2, Phase 3]
The MACANUDO trial evaluated ketamine for acute severe bronchospasm in ICU patients with asthma/critical illness, and has completed Phase 2 …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2024-05-21FDA Approved: ALBUTEROL SULFATE — Original Application (Armstrong Pharmaceuticals, Inc.)
FDA approved the original generic application for albuterol sulfate from Armstrong Pharmaceuticals, Inc. as a generic bronchodilator. It is …
-
FDA approval · 2023-06-23FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
FDA approved a supplemental application for ALBUTEROL SULFATE from Luoxin Aurovitas Pharma (Chengdu) Co., Ltd. under an ANDA for a generic p…
-
FDA approval · 2023-05-08FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Mylan Pharmaceuticals Inc.)
The FDA approved a supplemental application for albuterol sulfate submitted by Mylan Pharmaceuticals Inc. under ANDA214531. This action adds…
-
FDA approval · 2023-03-08FDA Approved: LEVALBUTEROL — Supplemental Application (Mylan Pharmaceuticals Inc.)
FDA approved a supplemental application for levalbuterol products from Mylan Pharmaceuticals Inc. under the ANDA program. This action confir…
-
CLINICAL_TRIALS trial_result · 2023-02-02Clinical Trial Update: Avoiding Neuromuscular Blockers to Reduce Complications [Phase 4]
Phase 4 clinical trial investigating avoidance of neuromuscular blockers to reduce complications in respiratory failure/infection cases; stu…
-
FDA approval · 2022-08-15FDA Approved: EPINEPHRINE — Original Application (International Medication Systems, Limited)
FDA approved a new epinephrine product under Original Application NDA211363 from International Medication Systems, Limited.
-
FDA approval · 2021-10-28FDA Approved: ALBUTEROL SULFATE — Supplemental Application (American Health Packaging)
FDA approved a supplemental application for albuterol sulfate, a generic inhalation drug, submitted by American Health Packaging.
-
FDA approval · 2021-06-01FDA Approved: ALBUTEROL SULFATE — Original Application (Hikma Pharmaceuticals USA Inc.)
The FDA approved Hikma Pharmaceuticals USA Inc.'s original application for albuterol sulfate. This approval makes a generic albuterol sulfat…
-
FDA approval · 2020-09-29FDA Approved: ALBUTEROL SULFATE — Supplemental Application (Padagis Israel Pharmaceuticals Ltd)
FDA approved a supplemental application for ALBUTEROL SULFATE submitted by Padagis Israel Pharmaceuticals Ltd.
-
CLINICAL_TRIALS trial_result · 2020-09-04Clinical Trial Update: Efficacy and Safety Evaluation in Recurrent Wheezing Attacks [Phase 3]
Phase 3 clinical trial evaluating efficacy and safety for recurrent wheezing attacks; results completed and posted in 2020.
-
FDA approval · 2020-06-19FDA Approved: TERBUTALINE SULFATE — Original Application (Upsher-Smith Laboratories, LLC)
FDA approval of the original application for Terbutaline Sulfate from Upsher-Smith Laboratories, a generic bronchodilator.
-
CLINICAL_TRIALS trial_result · 2020-06-05Clinical Trial Update: Effectiveness of Ipratropium Bromide in Preventing Exercise-induced Bronchoconstriction in Athletes [Phase 4]
Phase 4 trial assessing the effectiveness of ipratropium bromide in preventing exercise-induced bronchoconstriction in athletes; study compl…
-
FDA approval · 2020-05-14FDA Approved: ALBUTEROL — Original Application (Aurobindo Pharma Limited)
FDA approved the original application for ALBUTEROL (albuterol) inhalation product by Aurobindo Pharma Limited.
-
FDA approval · 2020-04-08FDA Approved: ALBUTEROL SULFATE — Original Application (American Health Packaging)
FDA approved the original application for albuterol sulfate, a generic product manufactured by American Health Packaging, expanding access t…
-
FDA approval · 2020-02-06FDA Approved: LEVALBUTEROL — Supplemental Application (Aurobindo Pharma Limited)
The FDA approved a supplemental application for levalbuterol from Aurobindo Pharma Limited.
-
FDA approval · 2019-09-06FDA Approved: ALBUTEROL SULFATE — Original Application (QUAGEN PHARMACEUTICALS LLC)
FDA approves QUAGEN PHARMACEUTICALS LLC's ALBUTEROL SULFATE original application, granting a generic albuterol sulfate product for relief of…
-
CLINICAL_TRIALS trial_result · 2019-07-01Clinical Trial Update: A Randomized, Double-Blind, Placebo-Controlled Study of Omalizumab for Idiopathic Anaphylaxis [Phase 2]
Phase 2 randomized trial evaluating omalizumab versus placebo for idiopathic anaphylaxis completed; results posted in 2019.
-
FDA approval · 2018-06-29FDA Approved: ALBUTEROL — Original Application (Rising Pharma Holdings, Inc.)
FDA approved the original application for albuterol filed by Rising Pharma Holdings, Inc. under ANDA207046.
-
CLINICAL_TRIALS research · 2017-11-06Clinical Trial Update: Change of Regional Ventilation During Spontaneous Breathing After Lung Surgery
This document provides a clinical trial update on changes in regional ventilation during spontaneous breathing after lung surgery. The study…
-
FDA approval · 2017-10-17FDA Approved: ALBUTEROL SULFATE — Original Application (Luoxin Aurovitas Pharma (Chengdu) Co., Ltd.)
FDA approved the original application for albuterol sulfate, a generic inhaled bronchodilator, manufactured by Luoxin Aurovitas Pharma (Chen…